Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial

AIM: We measured meningococcal serogroup C (MenC)-specific memory B-cell responses in infants by Enzyme-Linked Immunospot (ELISpot) following different MenC conjugate vaccine schedules to investigate the impact of priming on immune memory. METHODS: Infants aged 2 months were randomised to receive 1...

Full description

Bibliographic Details
Main Authors: Khatami, A, Clutterbuck, E, Thompson, A, McKenna, J, Pace, D, Birks, J, Snape, MD, Pollard, A
Format: Journal article
Language:English
Published: Public Library of Science 2014
_version_ 1797100713046704128
author Khatami, A
Clutterbuck, E
Thompson, A
McKenna, J
Pace, D
Birks, J
Snape, MD
Pollard, A
author_facet Khatami, A
Clutterbuck, E
Thompson, A
McKenna, J
Pace, D
Birks, J
Snape, MD
Pollard, A
author_sort Khatami, A
collection OXFORD
description AIM: We measured meningococcal serogroup C (MenC)-specific memory B-cell responses in infants by Enzyme-Linked Immunospot (ELISpot) following different MenC conjugate vaccine schedules to investigate the impact of priming on immune memory. METHODS: Infants aged 2 months were randomised to receive 1 or 2 doses of MenC-CRM197 at 3 or 3 and 4 months, 1 dose of MenC-TT at 3 months, or no primary MenC doses. All children received a Haemophilus influenzae type b (Hib)-MenC booster at 12 months. Blood was drawn at 5, 12, 12 months +6 days and 13 months of age. RESULTS: Results were available for 110, 103, 76 and 44 children from each group respectively. Following primary immunisations, and prior to the 12-month booster, there were no significant differences between 1- or 2-dose primed children in the number of MenC memory B-cells detected. One month following the booster, children primed with 1 dose MenC-TT had more memory B-cells than children primed with either 1-dose (p = 0.001) or 2-dose (p<0.0001) MenC-CRM197. There were no differences in MenC memory B-cells detected in children who received 1 or 2 doses of MenC-CRM197 in infancy and un-primed children. CONCLUSIONS: MenC-specific memory B-cell production may be more dependent on the type of primary vaccine used than the number of doses administered. Although the mechanistic differences between MenC-CRM197 and MenC-TT priming are unclear, it is possible that structural differences, including the carrier proteins, may underlie differential interactions with B- and T-cell populations, and thus different effects on various memory B-cell subsets. A MenC-TT/Hib-MenC-TT combination for priming/boosting may offer an advantage in inducing more persistent antibody. TRIAL REGISTRATION: EU Clinical Trials Register 2009-016579-31 ClinicalTrials.gov NCT01129518.
first_indexed 2024-03-07T05:41:31Z
format Journal article
id oxford-uuid:e5b9ecff-fc13-43f9-baca-60396da9ac19
institution University of Oxford
language English
last_indexed 2024-03-07T05:41:31Z
publishDate 2014
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:e5b9ecff-fc13-43f9-baca-60396da9ac192022-03-27T10:26:09ZEvaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trialJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e5b9ecff-fc13-43f9-baca-60396da9ac19EnglishSymplectic Elements at OxfordPublic Library of Science2014Khatami, AClutterbuck, EThompson, AMcKenna, JPace, DBirks, JSnape, MDPollard, AAIM: We measured meningococcal serogroup C (MenC)-specific memory B-cell responses in infants by Enzyme-Linked Immunospot (ELISpot) following different MenC conjugate vaccine schedules to investigate the impact of priming on immune memory. METHODS: Infants aged 2 months were randomised to receive 1 or 2 doses of MenC-CRM197 at 3 or 3 and 4 months, 1 dose of MenC-TT at 3 months, or no primary MenC doses. All children received a Haemophilus influenzae type b (Hib)-MenC booster at 12 months. Blood was drawn at 5, 12, 12 months +6 days and 13 months of age. RESULTS: Results were available for 110, 103, 76 and 44 children from each group respectively. Following primary immunisations, and prior to the 12-month booster, there were no significant differences between 1- or 2-dose primed children in the number of MenC memory B-cells detected. One month following the booster, children primed with 1 dose MenC-TT had more memory B-cells than children primed with either 1-dose (p = 0.001) or 2-dose (p<0.0001) MenC-CRM197. There were no differences in MenC memory B-cells detected in children who received 1 or 2 doses of MenC-CRM197 in infancy and un-primed children. CONCLUSIONS: MenC-specific memory B-cell production may be more dependent on the type of primary vaccine used than the number of doses administered. Although the mechanistic differences between MenC-CRM197 and MenC-TT priming are unclear, it is possible that structural differences, including the carrier proteins, may underlie differential interactions with B- and T-cell populations, and thus different effects on various memory B-cell subsets. A MenC-TT/Hib-MenC-TT combination for priming/boosting may offer an advantage in inducing more persistent antibody. TRIAL REGISTRATION: EU Clinical Trials Register 2009-016579-31 ClinicalTrials.gov NCT01129518.
spellingShingle Khatami, A
Clutterbuck, E
Thompson, A
McKenna, J
Pace, D
Birks, J
Snape, MD
Pollard, A
Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
title Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
title_full Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
title_fullStr Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
title_full_unstemmed Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
title_short Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
title_sort evaluation of the induction of immune memory following infant immunisation with serogroup c neisseria meningitidis conjugate vaccines exploratory analyses within a randomised controlled trial
work_keys_str_mv AT khatamia evaluationoftheinductionofimmunememoryfollowinginfantimmunisationwithserogroupcneisseriameningitidisconjugatevaccinesexploratoryanalyseswithinarandomisedcontrolledtrial
AT clutterbucke evaluationoftheinductionofimmunememoryfollowinginfantimmunisationwithserogroupcneisseriameningitidisconjugatevaccinesexploratoryanalyseswithinarandomisedcontrolledtrial
AT thompsona evaluationoftheinductionofimmunememoryfollowinginfantimmunisationwithserogroupcneisseriameningitidisconjugatevaccinesexploratoryanalyseswithinarandomisedcontrolledtrial
AT mckennaj evaluationoftheinductionofimmunememoryfollowinginfantimmunisationwithserogroupcneisseriameningitidisconjugatevaccinesexploratoryanalyseswithinarandomisedcontrolledtrial
AT paced evaluationoftheinductionofimmunememoryfollowinginfantimmunisationwithserogroupcneisseriameningitidisconjugatevaccinesexploratoryanalyseswithinarandomisedcontrolledtrial
AT birksj evaluationoftheinductionofimmunememoryfollowinginfantimmunisationwithserogroupcneisseriameningitidisconjugatevaccinesexploratoryanalyseswithinarandomisedcontrolledtrial
AT snapemd evaluationoftheinductionofimmunememoryfollowinginfantimmunisationwithserogroupcneisseriameningitidisconjugatevaccinesexploratoryanalyseswithinarandomisedcontrolledtrial
AT pollarda evaluationoftheinductionofimmunememoryfollowinginfantimmunisationwithserogroupcneisseriameningitidisconjugatevaccinesexploratoryanalyseswithinarandomisedcontrolledtrial